Lyra Skin Sciences

DERM-003 · Moderate-to-severe atopic dermatitis (combination device)

Phase 2aEnrollingDermatology / DeviceOn track

Executive summary

Combination device + topical study in atopic dermatitis. Enrolment is 4 weeks ahead of plan, all KPIs are within tolerance, and DBL is forecast on time.

Phase

Phase 2a

Stage

Enrolling

Health

On track

Milestone timeline

Showing completed, in-progress, and at-risk milestones. Planned future milestones are omitted from the sponsor view.

Nov 1, 2024forecast end Apr 12, 2027

FPI
Oct 28, 2024
Complete
25% enrolment
Mar 8, 2025
Complete
50% enrolment
Jul 12, 2025
Complete
75% enrolment
Oct 22, 2025
Complete
LPI
Feb 15, 2026
In progress

Signed deliverables

Updated live as deliverables are signed.

Essential Documents
filed and signed
Audit Trail
green
CSR draft
not yet released to sponsor

Request an update

Ask for a status update, request a document, or submit a question. The study lead is notified and you’ll see the response in this portal.